We are live on ! Find out more
JIP

Jaffetilchin Investment Partners Portfolio holdings

AUM $1.68B
1-Year Est. Return 22.81%
This Fund
S&P 500
This Quarter Est. Return
+7.38%
1 Year Est. Return
+22.81%
3 Year Est. Return
+78.52%
5 Year Est. Return
+93%
10 Year Est. Return
+323.14%
AUM
$1.45B
AUM Growth
+$600M
Cap. Flow
+$579M
Cap. Flow %
39.97%
Top 10 Hldgs %
44.13%
Holding
404
New
41
Increased
281
Reduced
41
Closed
35

Sector Composition

Rank Sector Weight
1 Technology 8.39%
2 Healthcare 4.38%
3 Consumer Discretionary 4.18%
4 Financials 3.07%
5 Communication Services 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FGD icon
351
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.59B
$207K 0.01%
7,979
BIP icon
352
Brookfield Infrastructure Partners
BIP
$18.2B
$203K 0.01%
+5,477
New +$198K
VATE icon
353
INNOVATE Corp
VATE
$105M
$203K 0.01%
+5,090
New +$206K
LITS
354
Lite Strategy Inc
LITS
$31.4M
$181K 0.01%
3,300
+1,650
+100% +$106K
ECOR icon
355
electroCore
ECOR
$84.7M
$177K 0.01%
9,934
+1,356
+16% +$35K
JRO
356
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$172K 0.01%
17,943
+5,801
+48% +$55.3K
NOK icon
357
Nokia
NOK
$57.6B
$167K 0.01%
32,305
+21,994
+213% +$106K
ET icon
358
Energy Transfer Partners
ET
$72.1B
$166K 0.01%
15,593
-2,871
-16% -$27.5K
PRTK
359
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$165K 0.01%
25,350
+12,675
+100% +$102K
BRW
360
Saba Capital Income & Opportunities Fund
BRW
$335M
$163K 0.01%
17,603
+10,065
+134% +$93.3K
THCX
361
DELISTED
AXS Cannabis ETF
THCX
$148K 0.01%
+1,184
New +$207K
DFTX
362
Definium Therapeutics
DFTX
$5.68B
$131K 0.01%
+2,505
New +$131K
SLVO icon
363
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$12.5M
$118K 0.01%
+973
New +$123K
JFR icon
364
Nuveen Floating Rate Income Fund
JFR
$1.25B
$102K 0.01%
10,182
+182
+2% +$1.76K
MDIA icon
365
Mediaco Holding
MDIA
$78.3M
$86K 0.01%
28,395
+11,806
+71% +$40.3K
MRKR icon
366
Marker Therapeutics
MRKR
$19.3M
$71K ﹤0.01%
2,550
-450
-15% -$11.8K
ETTX
367
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$29K ﹤0.01%
11,000
ADMA icon
368
ADMA Biologics
ADMA
$2.19B
$23K ﹤0.01%
14,250
ZOM
369
DELISTED
Zomedica Corp.
ZOM
$22K ﹤0.01%
41,000
+20,500
+100% +$19.1K
ADM icon
370
Archer Daniels Midland
ADM
$38.4B
-6,674
Closed -$380K
BAH icon
371
Booz Allen Hamilton
BAH
$9.43B
-2,971
Closed -$239K
BCO icon
372
Brink's
BCO
$4.69B
-2,644
Closed -$209K
SRTA
373
Strata Critical Medical Inc
SRTA
$533M
-11,199
Closed -$115K
BTG icon
374
B2Gold
BTG
$6.88B
-30,076
Closed -$130K
BYD icon
375
Boyd Gaming
BYD
$6.03B
-3,582
Closed -$211K

Similar funds

Jaffetilchin Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Jaffetilchin Investment Partners held 404 positions worth $1.45B, up 71% from $849M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Jaffetilchin Investment Partners deployed $579M of net new capital in Q2 2021, opening 41 new positions and adding to 281 existing holdings. Its largest new stake was First Trust Active Factor Large Cap Growth ETF: 100,502 shares worth $2.66M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 9.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was First Trust Enhanced Short Maturity ETF, an estimated $15.6M trimmed.

  • Jaffetilchin Investment Partners's largest Q2 2021 buy was First Trust Active Factor Large Cap Growth ETF: 100,502 shares worth $2.66M.
  • Jaffetilchin Investment Partners added most to iShares Core S&P Total US Stock Market ETF in Q2 2021, an estimated $70.4M increase.
  • Jaffetilchin Investment Partners's biggest Q2 2021 reduction was First Trust Enhanced Short Maturity ETF, cutting an estimated $15.6M.
  • Jaffetilchin Investment Partners fully exited Fidelity National Information Services in Q2 2021, selling an estimated $731K.
  • Jaffetilchin Investment Partners's ten largest holdings make up 44% of its $1.45B portfolio in Q2 2021.
  • Jaffetilchin Investment Partners opened 41 new positions and closed 35 in Q2 2021.
  • Jaffetilchin Investment Partners's portfolio value rose 71% quarter-over-quarter to $1.45B.

Based on Jaffetilchin Investment Partners's 13F filing for Q2 2021, filed 9 Aug 2021.